Conca V, Rossini D, Antoniotti C, Lonardi S, et al. Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study. J Clin Oncol 2026 Jan 8:JCO2501337. doi: 10.1200/JCO-25-01337.
PMID: 41505697